405 results on '"Shen, Zhen-zhou"'
Search Results
2. Supplementary Figure 1 from MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
3. Supplementary Tables 1 - 4 from MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
4. Translation on this Article from Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient Survival
5. Supplementary Figure Legend from MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
6. Supplementary Figure 2 from MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
7. Supplementary Figure 4 from MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
8. Supplementary Figure 3 from MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
9. The association between China’s Great famine and risk of breast cancer according to hormone receptor status: a hospital-based study
10. Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer
11. Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1–2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram
12. Effect of Large Tumor Size on Cancer-Specific Mortality in Node-Negative Breast Cancer
13. Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas
14. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer
15. Expression of CXCL14 and its anticancer role in breast cancer
16. Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram
17. Outcome of Pure Mucinous Breast Carcinoma Compared to Infiltrating Ductal Carcinoma: A Population-based Study from China
18. A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer
19. RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer
20. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
21. Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component
22. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes
23. Is Breast Cancer the Same Disease in Asian and Western Countries?
24. Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population
25. Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients
26. Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1
27. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations
28. Neoadjuvant combination chemotherapy with pegylated liposomal doxorubicin and vinorelbine for locally advanced breast cancer
29. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer
30. Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population
31. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China
32. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients
33. Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
34. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
35. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
36. Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients
37. Integrated gene expression profile predicts prognosis of breast cancer patients
38. Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
39. Identification of the functional role of AF1Q in the progression of breast cancer
40. ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor
41. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified
42. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge
43. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives
44. Development and Trends of Surgical Modalities for Breast Cancer in China: A Review of 16-Year Data
45. Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro
46. The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer
47. Breast conservative therapy in east part of China: a retrospective cohort study
48. Immediate breast reconstruction with latissimus dorsi musculocutaneous flap: A suitable option for chinese women after mastectomy
49. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients
50. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.